145 related articles for article (PubMed ID: 22772697)
1. Lamotrigine-induced neuroleptic malignant syndrome under risperidone treatment: a case report.
Motomura E; Tanii H; Usami A; Ohoyama K; Nakagawa M; Okada M
J Neuropsychiatry Clin Neurosci; 2012; 24(2):E38-9. PubMed ID: 22772697
[No Abstract] [Full Text] [Related]
2. Neuroleptic malignant syndrome caused by combination of risperidone and lithium in a patient with multiple medical comorbidities.
Kosehasanogullari SG; Akdede B; Akvardar Y; Akan M; Tunca Z
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1147-8. PubMed ID: 17513032
[No Abstract] [Full Text] [Related]
3. Neuroleptic malignant syndrome induced by lamotrigine.
Ishioka M; Yasui-Furukori N; Hashimoto K; Sugawara N
Clin Neuropharmacol; 2013; 36(4):131-2. PubMed ID: 23783003
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive lamotrigine as a possible mania inducer in bipolar patients.
Raskin S; Teitelbaum A; Zislin J; Durst R
Am J Psychiatry; 2006 Jan; 163(1):159-60. PubMed ID: 16390907
[No Abstract] [Full Text] [Related]
5. Neuroleptic malignant syndrome and risperidone: a case report.
Bonwick RJ; Hopwood MJ; Morris PL
Aust N Z J Psychiatry; 1996 Jun; 30(3):419-21. PubMed ID: 8839956
[TBL] [Abstract][Full Text] [Related]
6. Case study. Risperidone-Induced neuroleptic malignant syndrome in an adolescent.
Robb AS; Chang W; Lee HK; Cook MS
J Child Adolesc Psychopharmacol; 2000; 10(4):327-30. PubMed ID: 11191694
[TBL] [Abstract][Full Text] [Related]
7. Lithium-induced fatal neuroleptic malignant syndrome in a patient not being concomitantly treated with commonly offending agents.
Argyriou AA; Drakoulogona O; Karanasios P; Kouliasa L; Leonidou L; Giannakopoulou F; Goudas P; Makris N
J Pain Symptom Manage; 2012 Dec; 44(6):e4-6. PubMed ID: 23217454
[No Abstract] [Full Text] [Related]
8. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
Nierenberg AA; Ostacher MJ; Calabrese JR; Ketter TA; Marangell LB; Miklowitz DJ; Miyahara S; Bauer MS; Thase ME; Wisniewski SR; Sachs GS
Am J Psychiatry; 2006 Feb; 163(2):210-6. PubMed ID: 16449473
[TBL] [Abstract][Full Text] [Related]
9. International Consensus Group on the evidence-based pharmacologic treatment of bipolar I and II depression.
J Clin Psychiatry; 2008 Oct; 69(10):1632-46. PubMed ID: 19192447
[No Abstract] [Full Text] [Related]
10. Lamotrigine and clozapine for bipolar disorder.
Calabrese JR; Gajwani P
Am J Psychiatry; 2000 Sep; 157(9):1523. PubMed ID: 10964878
[No Abstract] [Full Text] [Related]
11. Agranulocytosis associated with lamotrigine.
Solvason HB
Am J Psychiatry; 2000 Oct; 157(10):1704. PubMed ID: 11007735
[No Abstract] [Full Text] [Related]
12. Atypical neuroleptic malignant syndrome associated with risperidone treatment.
Newman M; Adityanjee ; Jampala C
Am J Psychiatry; 1997 Oct; 154(10):1475. PubMed ID: 9326841
[No Abstract] [Full Text] [Related]
13. Relative effectiveness of adjunctive risperidone on manic and depressive symptoms in mixed mania.
Singh V; Bowden CL; Mintz J
Int Clin Psychopharmacol; 2013 Mar; 28(2):91-5. PubMed ID: 23238761
[TBL] [Abstract][Full Text] [Related]
14. High-dose vitamin E plus vitamin B6 treatment of risperidone-related neuroleptic malignant syndrome.
Dursun SM; Oluboka OJ; Devarajan S; Kutcher SP
J Psychopharmacol; 1998; 12(2):220-1. PubMed ID: 9694035
[TBL] [Abstract][Full Text] [Related]
15. Lamotrigine in psychiatry: pharmacology and therapeutics.
Jefferson JW
CNS Spectr; 2005 Mar; 10(3):224-32. PubMed ID: 15744223
[TBL] [Abstract][Full Text] [Related]
16. [Intensive care treatment for neuroleptic malignant syndrome].
Hensel M; Böhler K; Marnitz R; Binder C; von Brevern M
Anasthesiol Intensivmed Notfallmed Schmerzther; 2010 Jul; 45(7-8):448-55. PubMed ID: 20665353
[TBL] [Abstract][Full Text] [Related]
17. Neuroleptic malignant syndrome in juvenile neuronal ceroid lipofuscinosis associated with low-dose risperidone therapy.
Vercammen L; Buyse GM; Proost JE; Van Hove JL
J Inherit Metab Dis; 2003; 26(6):611-2. PubMed ID: 14605508
[TBL] [Abstract][Full Text] [Related]
18. Neuroleptic malignant syndrome with risperidone.
Gleason PP; Conigliaro RL
Pharmacotherapy; 1997; 17(3):617-21. PubMed ID: 9165568
[TBL] [Abstract][Full Text] [Related]
19. [Neuroleptic malignant syndrome in users of risperidone].
Vorel SK; Bos F; Vorel-Havelkova E; Brombacher PJ
Ned Tijdschr Geneeskd; 2005 Jan; 149(3):159-60; author reply 160. PubMed ID: 15693596
[No Abstract] [Full Text] [Related]
20. [Neuroleptic malignant syndrome in users of risperidone].
Kroon JG
Ned Tijdschr Geneeskd; 2005 Jan; 149(3):157-8; author reply 158. PubMed ID: 15693594
[No Abstract] [Full Text] [Related]
[Next] [New Search]
